InvestorsObserver
×
News Home

Will Annovis Bio Inc (ANVS) Outperform the Rest of the Stocks in the Healthcare Sector?

Thursday, November 30, 2023 01:45 PM | InvestorsObserver Analysts

Mentioned in this article

Will Annovis Bio Inc (ANVS) Outperform the Rest of the Stocks in the Healthcare Sector?

Annovis Bio Inc (ANVS) is around the top of the Healthcare sector according to InvestorsObserver. ANVS received an overall rating of 46, which means that it scores higher than 46% of stocks. Additionally, Annovis Bio Inc scored a 73 in the Healthcare sector, ranking it higher than 73% of stocks in that sector.

Overall Score - 46
ANVS has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on ANVS!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 46 would rank higher than 46 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Annovis Bio Inc Stock Today?

Annovis Bio Inc (ANVS) stock is higher by 6.24% while the S&P 500 is down -0.2% as of 1:41 PM on Thursday, Nov 30. ANVS is up $0.52 from the previous closing price of $8.33 on volume of 326,425 shares. Over the past year the S&P 500 is higher by 11.31% while ANVS is down -34.15%. ANVS lost -$4.27 per share the over the last 12 months. Click Here to get the full Stock Report for Annovis Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App